Spero Therapeutics (SPRO) Restructuring Costs (2022 - 2025)

Spero Therapeutics has reported Restructuring Costs for 3 years, with the latest figure at $83000.0 in Q2 2025.

• For the quarter ending Q2 2025, Restructuring Costs changed N/A year-over-year to $83000.0; the trailing twelve-month figure through Mar 2026 stood at $83000.0 (down 92.11% YoY), and the FY2025 full-year result was $258000.0, down 70.58% from the prior year.
• Restructuring Costs for Q2 2025 stood at $83000.0, down from $175000.0 in the prior quarter.
• The five-year high for Restructuring Costs was $11.8 million in Q2 2022, with the low at -$8.6 million in Q4 2022.
• Historically, Restructuring Costs has averaged $702166.7 across 3 years, with a median of $129000.0 in 2025.